Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

More On GLAXO.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

GlaxoSmithkline Pharmaceuticals Limited (GLAXO.NS)

-NSE
2,500.40 Up 18.90(0.76%) Jul 11, 5:59AM EDT
Prev Close:2,481.50
Open:2,481.50
Bid:2,500.40
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:2,480.00 - 2,512.50
52wk Range:2,160.00 - 3,054.50
Volume:11,765
Avg Vol (3m):11,048
Market Cap:211.79B
P/E (ttm):43.97
EPS (ttm):56.87
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Key Statistics

Forward P/E (1 yr):34.96
P/S (ttm):8.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :N/A
Quarterly EPS Est (Dec-13) :N/A
Mean Recommendation*:3.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades prescription medicines for a range of therapeutic areas, including analgesic, anti-infecti... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback